Carcino-embryonic antigen calibrator test method

A test method and technology of calibrator, applied in the direction of measuring devices, instruments, scientific instruments, etc., can solve the problems that cannot be used as the basis for early diagnosis or diagnosis of malignant tumors, and there is no standardized and unified test method, so as to facilitate mass production and test The effect of accurate value and low cost
CN107941791AActive Publication Date: 2018-04-20JIANGSU ZECEN BIOTECH CO LTD
9 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN Β· China
Current Assignee / Owner
JIANGSU ZECEN BIOTECH CO LTD
Publication Date
2018-04-20

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

A carcino-embryonic antigen calibrator test method is disclosed. The carcino-embryonic antigen calibrator test method includes the following preparation steps: 1) dividing to-be-tested calibrators into two groups, respectively testing the luminescence value of the to-be-tested calibrators, a working reference product and a quality control product; 2) using the working reference product as a curvefor fitting of the to-be-tested calibrators and the quality control product, and calculating the values of the to-be-tested calibrators and the quality control product; 3) using the to-be-tested calibrators as a curve for fitting of the quality control product, and calculating the values of the to-be-tested calibrators; 4) assigning, to be more specific, assigning the sub-packaged calibrators; and5) verifying, to be more specific, respectively determining inter-bottle homogeneity and the in-bottle homogeneity. The carcino-embryonic antigen calibrator test method can accurately detect the calibrator of a carcino-embryonic antigen (CEA), is accurate in measurement value, can effectively monitor a test value of a sample in a clinical test, and has the advantages of low cost, high efficiency,accurate assignment, mass production convenience compared with a test method used in the prior art.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the technical field of in vitro diagnostic testing, in particular to a method for testing a cancer blank antigen calibrator. Background technique

[0002] Carcinoembryonic antigen (CEA) is a carbohydrate antigen with a specific determinant of human embryonic antigen, which is an important tumor-associated antigen. synthesized by hepatocytes. In 1965, Gold and Freedman first discovered it from fetal and colon cancer tissues, so they called it carcinoembryonic antigen. Its coding gene is located on chromosome 19 and is a polysaccharide-protein complex with a molecular weight of 22KD, 45% of which is protein.

[0003] CEA is a non-organ-specific tumor-associated antigen, which mainly exists in rectal and colon cancer tissues and fetal intestinal mucosa. Most of the tumors that secrete CEA are located in hollow organs, such as the gastrointestinal tract, respiratory tract, and urinary tract. Under normal circumstances, CEA is me...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More